← Back to Clinical Trials
Recruiting NCT06963242

NCT06963242 Evaluating the Accuracy of Dynamic Navigation in Implant Surgery for Full Arch Prosthesis

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06963242
Status Recruiting
Phase
Sponsor University of Medicine and Pharmacy at Ho Chi Minh City
Condition Accuracy of Dynamic Navigation System in Implant Placement for Full Arch Prosthesis Rehabilitation
Study Type INTERVENTIONAL
Enrollment 12 participants
Start Date 2024-07-01
Primary Completion 2025-08-31

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age N/A
Study Type INTERVENTIONAL
Interventions
Dynamic Navigation System for Implant Placement Using Bone Screws as LandmarksDynamic Navigation System for Implant Placement Using Remaining Teeth as Landmarks

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 12 participants in total. It began in 2024-07-01 with a primary completion date of 2025-08-31.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

Study Objective: This study aims to evaluate the accuracy of the Dynamic Navigation System in performing implant placement for full arch prosthesis rehabilitation. This system uses landmarks, including bone screws fixed to the bone (Group 1), and landmarks on remaining teeth to be extracted (Group 2), to accurately determine the placement of the implants Participants: Patients aged 18 and older, who have total tooth loss or partial tooth loss, and are candidates for full arch implant-supported prosthesis rehabilitation, are invited to participate, provided they meet the necessary health requirements for surgery. Group 1: Patients who have total tooth loss or partial tooth loss but do not meet the following conditions: 1. Having at least 3 remaining teeth or roots with mobility no greater than grade 1, and 2. The remaining teeth are distributed with at least 1 tooth in the front and 1 tooth in the back on each side of the arch. These patients will have bone screws placed on the bone to serve as landmarks for implant placement using the dynamic navigation system. Group 2: Patients who have at least 3 remaining teeth, all with mobility no greater than grade 1, and at least one tooth in the front and one in the back on each side of the arch. These teeth will serve as landmarks for implant placement. Study Methodology: Group 1: Patients who have total or partial tooth loss, and do not meet the conditions of having at least 3 remaining teeth with mobility no greater than grade 1, and having at least one tooth in the front and one in the back on each side, will have bone screws placed on the bone as landmarks for implant placement. Group 2: Patients with at least 3 remaining teeth with mobility no greater than grade 1, and at least one tooth in the front and one in the back on each side, will use these teeth as landmarks for implant placement. After surgery, the implant deviation from the planned implant data will be evaluated to assess the accuracy of implant placement. Factors such as implant position deviation, surgery time, and complications will be evaluated to compare the effectiveness between the two groups. Benefits and Risks: 1. Benefits: 1. Improved accuracy in implant placement using the Dynamic Navigation System. 2. Cost of using the Dynamic Navigation System and the cost of bone screws for patients without sufficient remaining teeth are covered by the study. 3. Scientific contribution to improving implant placement methods for future patients. 2. Risks: 1. Surgical risks including infection, pain, swelling, and potential implant failure, which can occur even without the use of the dynamic navigation system. 2. Radiation exposure from imaging tests, particularly CBCT scans, will be required. The radiation exposure is minimal and within safe limits. 3. Slight increase in surgery time, typically 2-5 minutes longer than traditional surgery, for preparation and calibration of the navigation system to ensure its proper functionality. 4. For Group 1 participants, bone screws (4-6 screws) will be placed along the jaw arch where the implants are to be positioned.

Eligibility Criteria

Inclusion Criteria: * Patients who are fully edentulous or have partial edentulism and are in need of full arch prosthesis rehabilitation. * Aged 18 years and older. * Individuals in good general health (American Society of Anesthesiologists (ASA) class I or II) * Willing to participate in the study and provide informed consent. Exclusion Criteria: * Any serious medical (ASA class III or IV) or psychiatric conditions. * Pregnant or breastfeeding women. * General or Local Health Conditions Affecting Surgery: Systemic/local conditions that affect surgical healing, wound healing, and bone integration or use of medications such as steroids, bisphosphonates, or other drugs affecting bone health; smoking more than 10 cigarettes per day; acute infections at the planned implant site that have not been treated. * Patients with a limited mouth opening of less than 40mm.

Contact & Investigator

Central Contact

Nhiem Cao Tran

✉ tcnhiem.nt22@ump.edu.vn

📞 +84936221609

Principal Investigator

Nhiem Cao Tran

PRINCIPAL INVESTIGATOR

University of Medicine and Pharmacy at Ho Chi Minh City

Frequently Asked Questions

Who can join the NCT06963242 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, studying Accuracy of Dynamic Navigation System in Implant Placement for Full Arch Prosthesis Rehabilitation. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06963242 currently recruiting?

Yes, NCT06963242 is actively recruiting participants. Contact the research team at tcnhiem.nt22@ump.edu.vn for enrollment information.

Where is the NCT06963242 trial being conducted?

This trial is being conducted at Ho Chi Minh City, Vietnam, Ho Chi Minh City, Vietnam.

Who is sponsoring the NCT06963242 clinical trial?

NCT06963242 is sponsored by University of Medicine and Pharmacy at Ho Chi Minh City. The principal investigator is Nhiem Cao Tran at University of Medicine and Pharmacy at Ho Chi Minh City. The trial plans to enroll 12 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology